| Mary D O'rourke, MD | |
|
915 Highland Blvd, Bozeman, MT 59715-6902 | |
| (406) 414-5000 | |
| Not Available |
| Full Name | Mary D O'rourke |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 38 Years |
| Location | 915 Highland Blvd, Bozeman, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033125091 | NPI | - | NPPES |
| 1033125091 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD00033119 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bozeman Health Deaconess Hospital | Bozeman, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bozeman Health Deaconess Hospital | 4688984164 | 233 |
News Archive
The Centers for Medicare & Medicaid Services (CMS) has announced that reimbursements for Medicare heart transplant cases performed at Wake Forest University Baptist Medical Center will continue uninterrupted.
A new study published on the preprint server medRxiv* in November 2020 reports some of the unique elements of COVID-19-induced CRS and how understanding these distinctive characteristics of the disease could help in formulating specific interventions and therapies.
Salix Pharmaceuticals, Ltd. today announced the presentation of two analyses of data from its Phase 3 pivotal clinical trials, TARGET 1 and 2, demonstrating a 14-day course of XIFAXAN 550 mg (rifaximin) taken three times daily achieved adequate relief of symptoms of non-constipation irritable bowel syndrome (non-C IBS) in a significantly greater proportion of patients compared with placebo.
In the face of growing numbers of uninsured and low-income patients due to the economy, some free clinics are having difficulty meeting the increased demand, the Cleveland Plain Dealer reports.
Two years after the Food and Drug Administration Amendments Act of 2007 gave FDA new powers to require Risk Evaluation and Mitigation Strategies for higher risk drugs and biologics, a new report concludes that an optimal future for REMS is possible if the agency adopts a systems approach when designing REMS programs and takes advantage of new technologies - from electronic medical records to genetic testing - that are changing the way medicine is practiced.
› Verified 7 days ago
| Entity Name | Bozeman Health Deaconess Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619347390 PECOS PAC ID: 4688984164 Enrollment ID: O20151112002559 |
News Archive
The Centers for Medicare & Medicaid Services (CMS) has announced that reimbursements for Medicare heart transplant cases performed at Wake Forest University Baptist Medical Center will continue uninterrupted.
A new study published on the preprint server medRxiv* in November 2020 reports some of the unique elements of COVID-19-induced CRS and how understanding these distinctive characteristics of the disease could help in formulating specific interventions and therapies.
Salix Pharmaceuticals, Ltd. today announced the presentation of two analyses of data from its Phase 3 pivotal clinical trials, TARGET 1 and 2, demonstrating a 14-day course of XIFAXAN 550 mg (rifaximin) taken three times daily achieved adequate relief of symptoms of non-constipation irritable bowel syndrome (non-C IBS) in a significantly greater proportion of patients compared with placebo.
In the face of growing numbers of uninsured and low-income patients due to the economy, some free clinics are having difficulty meeting the increased demand, the Cleveland Plain Dealer reports.
Two years after the Food and Drug Administration Amendments Act of 2007 gave FDA new powers to require Risk Evaluation and Mitigation Strategies for higher risk drugs and biologics, a new report concludes that an optimal future for REMS is possible if the agency adopts a systems approach when designing REMS programs and takes advantage of new technologies - from electronic medical records to genetic testing - that are changing the way medicine is practiced.
› Verified 7 days ago
| Entity Name | Barrett Hospital Development Corporation |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1396286480 PECOS PAC ID: 4082904487 Enrollment ID: O20170223001015 |
News Archive
The Centers for Medicare & Medicaid Services (CMS) has announced that reimbursements for Medicare heart transplant cases performed at Wake Forest University Baptist Medical Center will continue uninterrupted.
A new study published on the preprint server medRxiv* in November 2020 reports some of the unique elements of COVID-19-induced CRS and how understanding these distinctive characteristics of the disease could help in formulating specific interventions and therapies.
Salix Pharmaceuticals, Ltd. today announced the presentation of two analyses of data from its Phase 3 pivotal clinical trials, TARGET 1 and 2, demonstrating a 14-day course of XIFAXAN 550 mg (rifaximin) taken three times daily achieved adequate relief of symptoms of non-constipation irritable bowel syndrome (non-C IBS) in a significantly greater proportion of patients compared with placebo.
In the face of growing numbers of uninsured and low-income patients due to the economy, some free clinics are having difficulty meeting the increased demand, the Cleveland Plain Dealer reports.
Two years after the Food and Drug Administration Amendments Act of 2007 gave FDA new powers to require Risk Evaluation and Mitigation Strategies for higher risk drugs and biologics, a new report concludes that an optimal future for REMS is possible if the agency adopts a systems approach when designing REMS programs and takes advantage of new technologies - from electronic medical records to genetic testing - that are changing the way medicine is practiced.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary D O'rourke, MD 915 Highland Blvd, Bozeman, MT 59715-6902 Ph: (406) 414-5000 | Mary D O'rourke, MD 915 Highland Blvd, Bozeman, MT 59715-6902 Ph: (406) 414-5000 |
News Archive
The Centers for Medicare & Medicaid Services (CMS) has announced that reimbursements for Medicare heart transplant cases performed at Wake Forest University Baptist Medical Center will continue uninterrupted.
A new study published on the preprint server medRxiv* in November 2020 reports some of the unique elements of COVID-19-induced CRS and how understanding these distinctive characteristics of the disease could help in formulating specific interventions and therapies.
Salix Pharmaceuticals, Ltd. today announced the presentation of two analyses of data from its Phase 3 pivotal clinical trials, TARGET 1 and 2, demonstrating a 14-day course of XIFAXAN 550 mg (rifaximin) taken three times daily achieved adequate relief of symptoms of non-constipation irritable bowel syndrome (non-C IBS) in a significantly greater proportion of patients compared with placebo.
In the face of growing numbers of uninsured and low-income patients due to the economy, some free clinics are having difficulty meeting the increased demand, the Cleveland Plain Dealer reports.
Two years after the Food and Drug Administration Amendments Act of 2007 gave FDA new powers to require Risk Evaluation and Mitigation Strategies for higher risk drugs and biologics, a new report concludes that an optimal future for REMS is possible if the agency adopts a systems approach when designing REMS programs and takes advantage of new technologies - from electronic medical records to genetic testing - that are changing the way medicine is practiced.
› Verified 7 days ago
Dr. Melissa Rae Reily, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 931 Highland Blvd Ste 3260, Bozeman, MT 59715 Phone: 406-414-2410 Fax: 406-414-5198 | |
Dr. Tory Beth Katz, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 Highland Blvd, Bozeman, MT 59715 Phone: 405-551-5050 | |
Mark Robert Hancock, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 931 Highland Blvd Ste 3130, Bozeman, MT 59715 Phone: 406-414-5070 Fax: 406-414-5029 | |
Dr. Pamela Hiebert, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 937 Highland Blvd Ste 5410, Bozeman, MT 59715 Phone: 406-414-2400 | |
Dr. Alexander Taylor, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 Highland Blvd, Bozeman, MT 59715 Phone: 406-414-3959 | |
Dr. Steven Lyle Rowley Shaneyfelt, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 931 Highland Blvd, #3350, Bozeman, MT 59715 Phone: 406-586-3309 Fax: 406-522-8498 |